Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 09688 ZAI LAB-B > Detailed Quotes

09688 ZAI LAB-B

27.400
-1.700-5.84%
Market Close 09/30 16:08 CCT
High
27.600
Open
27.500
Turnover
15.86M
Low
26.400
Pre Close
29.100
Volume
583.90K
Market Cap
26.32B
P/E(TTM)
Loss
52wk High
84.200
Shares
960.52M
P/E(Static)
Loss
52wk Low
17.600
Float Cap
26.32B
Bid/Ask %
66.02%
Historical High
151.200
Shs Float
960.52M
Volume Ratio
0.54
Historical Low
17.600
Dividend TTM
--
Div Yield TTM
--
P/B
2.77
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.06%
Amplitude
4.12%
Avg Price
27.168
Lot Size
100
Float Cap
26.32B
Bid/Ask %
66.02%
Historical High
151.200
Shs Float
960.52M
Volume Ratio
0.54
Historical Low
17.600
Dividend TTM
--
P/B
2.77
Dividend LFY
--
Turnover Ratio
0.06%
Amplitude
4.12%
Avg Price
27.168
Lot Size
100
Price Forecast

No Data

News

Comment

Company Overview More
Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals dedicated to the discovery or licensing, development and commercialization of proprietary therapies to address a large number of unmet medical needs in the Chinese market, including oncology, autoimmunity and infectious diseases. The company has a range of patent candidates from the discovery phase to the later stages of the clinical program. It includes Niraparib (ZL-2306), ZL-2103, ZL-1101 and so on.
CEO: Ying Du
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...